Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Ikuko Ueda-HayakawaY HamaguchiHanako Koguchi-YoshiokaSei-Ichiro MotegiT YamaokaS MiyakeA HigashiH OkamotoK TakeharaM FujimotoPublished in: The British journal of dermatology (2018)
Seven patients were confirmed to have anti-TIF-1β antibody without any other MSAs, including TIF-1α/γ antibodies, and six of them were diagnosed with DM. We suggest that anti-TIF-1β antibody is an MSA, and that it is associated with clinically amyopathic DM or DM with mild myopathy.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- end stage renal disease
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- newly diagnosed
- ejection fraction
- late onset
- chronic kidney disease
- glycemic control
- peritoneal dialysis
- prognostic factors
- transcription factor
- early onset
- insulin resistance
- skeletal muscle
- myasthenia gravis